Chinook Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Chinook Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 88% to $6,128,000. Profit margin reached -3013%. Total operating expenses were $179,224,000.
Profit Margin
| 2015 | 72.97M | -39.20M | -53.73% |
|---|---|---|---|
| 2016 | 50.68M | -91.14M | -179.85% |
| 2017 | 17.23M | -91.86M | -532.88% |
| 2018 | 15.08M | -95.35M | -632.05% |
| 2019 | 17.25M | -46.85M | -271.47% |
| 2020 | 827K | -81.62M | -9869.65% |
| 2021 | 51.62M | -101.30M | -196.22% |
| 2022 | 6.12M | -184.61M | -3012.65% |
KDNY Income Statement (2015 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 6.12M | 51.62M | 827K | 17.25M | 15.08M | 17.23M | 50.68M | 72.97M |
Cost of revenue | 1.72M | 1.68M | 422K | 554K | 584K | 559K | 549K | 89K |
Gross profit | 4.40M | 49.93M | 405K | 16.70M | 14.50M | 16.68M | 50.13M | 72.89M |
Operating exp. | ||||||||
Research and development | 141.21M | 96.98M | 36.05M | 17.01M | 75.83M | 89.38M | 87.71M | 58.64M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 179.22M | 130.57M | 55.54M | 19.96M | 115.86M | 123.13M | 121.99M | 86.45M |
Operating income | -185.08M | -99.03M | -56.22M | -19.96M | -101.36M | -106.45M | -71.86M | -13.56M |
Other income (expenses), net | 4.80M | -170K | -27.39M | -26.55M | 5.22M | 3.22M | 2.17M | -25.74M |
Income before tax | -180.27M | -99.20M | -83.62M | -46.51M | -96.14M | -103.22M | -69.68M | -39.30M |
Income tax expense | 4.34M | 2.09M | -2.00M | 332K | 783K | 11.36M | -21.46M | -99K |
Net income | -184.61M | -101.30M | -81.62M | -46.85M | -95.35M | -91.86M | -91.14M | -39.20M |
Earnings per share | ||||||||
Basic EPS | -2.87 | -2.22 | -6.2 | -1.11 | -0.00 | -0.00 | -0.00 | -0.00 |
Diluted EPS | -2.87 | -2.22 | -6.2 | -1.11 | -0.00 | -0.00 | -0.00 | -0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |